+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma

Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma

Surgery (St Louis) 119(3): 316-325

Background: Measuring serum cytokines, pituitary hormones, or acute phase proteins during or after surgery is not an optimal method for quantifying the impact of surgical procedures. In an effort to assess surgical stress by means of the immune response, we focused on changes in cell-mediated and antibody-mediated immunity as illustrated by the type 1/type 2 T-helper (Th1/Th2) cell balance. The sensitivity of this approach was evaluated by comparing laparoscopic and conventional cholecystectomy (LCE, CCE). Methods: In a pragmatic prospective study 43 patients with symptomatic cholelithiasis were operated on either by LCE (n = 25) or CCE (n = 18). Blood sampling was done 24 hours before surgery, immediately before incision, and 2, 24, and 48 hours after surgery. Cell surface markers and cytokine production were used to characterize the Th1/Th2 balance and were measured by means of flow cytometry and enzyme-linked immunosorbent assay techniques. Results: Activation of Th2 cells evokes the production and secretion of interleukin-4 (IL-4), which up-regulates the expression of immunoglobulin E receptors (Fo-epsilon-RII, CD23) on B cells. Phytohemagglutinin-induced IL-4 production in freshly isolated peripheral blood mononuclear cells from patients increased more after CCE than LCE (IL-4, +41% versus +17%; p lt 0.05). Also the expression of CD23 on B cells was higher after CCE than LCE (+146% versus +63%; p lt 0.01). CD30, a membrane molecule that belongs to the tumor necrosis factor receptor superfamily and probably is an important indicator of Th2 activity, was more elevated on T cells from patients who underwent CCE. The Th1 response, characterized by phytohemagglutinin-induced IFN-gamma secretion in peripheral blood mononuclear cells and up-regulation of human leukocyte antigen-DR expression on monocytes, was lower after CCE than after LCE. Conclusions: This study shows that surgical stress induces a shift in the Th1/Th2 balance toward Th2, suggesting that cell-mediated immunity is down-regulated and antibody-mediated immunity is up-regulated after surgery. The evaluation of this shift may be clinically meaningful and help quantify even less invasive surgical procedures. Men comparing CCE and LCE in this not strictly randomized study, we found LCE to be the less stressful procedure.

(PDF emailed within 0-6 h: $19.90)

Accession: 009495183

Download citation: RISBibTeXText

PMID: 8619187

DOI: 10.1016/s0039-6060(96)80118-8

Related references

The severity of infection induces a shift in the type 1/Type 2 T-helper cell balance in patients with or without peritonitis. Surgical Infections 4(3): 247-254, 2003

Cell penetrable-mouse forkhead box P3 suppresses type 1 T helper cell-mediated immunity in a murine model of delayed-type hypersensitivity. Experimental and Therapeutic Medicine 13(2): 421-428, 2017

T-helper cell 2-driven immunity in pregnancy as a determinant of antiplasmodial antibody half-life through regulation of Fc-receptor-mediated clearance. Journal of Infectious Diseases 208(4): 705-705, 2013

Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. Journal of Immunology 159(5): 2484-2491, 1997

Regulation of antibacterial (antitubercular) immunity mediated by T-helper type-17 lymphocytes. Molecular Biology 47(6): 769-775, 2013

T-lymphocyte-helper type 17 mediated regulation of antibacterial (antituberculosis) immunity. Molekuliarnaia Biologiia 47(6): 883-890, 2015

Mechanisms of regulation of cell-mediated immunity: anti-I-A alloantisera interfere with induction and expression of T-cell-mediated immunity to cell-bound antigen in vivo. Clinical Immunology and Immunopathology 15(3): 279-292, 1980

Inhibition of primary and recall allergen-specific T helper cell type 2-mediated responses by a T helper cell type 1 stimulus. Journal of Immunology 159(1): 107-116, 1997

Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6. Journal of Leukocyte Biology 87(6): 1011-1018, 2010

Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology. Proceedings of the National Academy of Sciences of the United States of America 91(17): 8097-8101, 1994

Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis is mediated by IL-4 and antigen-specific T cell factors. Clinical Immunology & Immunopathology 67(3 PART 1): 240-248, 1993

Negative feedback regulation of T helper type 1 (Th1)/Th2 cytokine balance via dendritic cell and natural killer T cell interactions. Blood 106(5): 1685-1693, 2005

Immunobiological studies on experimental visceral leishmaniasis. II. Adherent cell-mediated down-regulation of delayed-type hypersensitivity response and up-regulation of B cell activation. European Journal of Immunology 22(8): 2041-2045, 1992

Mechanisms of regulation of cell mediated immunity anti i a allo anti sera interfere with induction and expression of thymus derived cell mediated immunity to cell bound antigen in vivo. Clinical Immunology & Immunopathology 15(3): 279-292, 1980

Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo. Human Gene Therapy 12(9): 1091-1102, 2001